Evidence map›Paper›PMID 41631226›Full record

ReviewCureus2025

Nanohydroxyapatite and Bioactive Glass Composites in Bone Regeneration: A Systematic Review.

Shrinit Babel, Sunit Babel, Syed R Peeran, Binu Pratap

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shrinit BabelMorsani College of Medicine, University of South Florida, Tampa, USA.
Sunit BabelJudy Genshaft Honors College, University of South Florida, Tampa, USA.
Syed R PeeranNeurosurgery, Christian Medical College, Vellore, IND.
Binu PratapHand and Leprosy Reconstructive Surgery, Christian Medical College, Vellore, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone tissue engineering is a pillar of regenerative medicine; traditional bone autografts, allografts, and metallic implants face difficulties due to donor site morbidity, risks of infection, and poor integration with the host bone. Nanohydroxyapatite (nHA) has become a popular synthetic tissue-engineered approach, although its brittleness and low fracture toughness limit its applications. This systematic review explores nHA-bioactive glass composites (HAGNs) as promising solutions for bone regeneration, analyzing their biocompatibility, osteoconductivity, and mechanical properties. This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search strategy was employed across multiple databases from January 2000 to February 2024, using MeSH terms related to hydroxyapatite (HA), glass nanoparticles, and bone regeneration. Eligible studies included peer-reviewed articles reporting outcomes relevant to bone healing or tissue engineering using HA glass nanoparticles. The search yielded 57 records, with 15 studies meeting the inclusion criteria after screening and selection. These studies explored various fabrication methods and consolidation techniques for nHA-based scaffolds, highlighting their improved biocompatibility, osteoconductivity, and potential for bone regeneration. Limitations involved long drying periods, the need for specific consolidation conditions, and more studies to confirm long-term performance. Findings underscored the importance of preserving key properties of nHA, such as low crystallinity and nanoscale dimensions, to mimic natural bone tissue effectively. nHA and bioactive glass composites show significant potential in bone tissue engineering. They offer the combination of biocompatibility, osteoconductivity, and mechanical strength necessary for effective bone regeneration. Further research is needed to facilitate the clinical translation of these biomaterials.

Indexed as

bioactive glassbone tissue regenerationglass nanoparticleshydroxyapatitesystematic review

Identifiers

PMID41631226
PMCPMC12860566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.